US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Indian Herb Paste

Reason Unapproved new drug

McDaniel Life-Line LLC D-1111-2019
Class II · Moderate risk Terminated

MAGnesium 2 gm sulfate

Reason Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Avella of Deer Valley, Inc. Store 38 NDC 42852-907-05 D-1000-2019
Class II · Moderate risk Terminated

MAGnesium 2gm sulfate

Reason Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Avella of Deer Valley, Inc. Store 38 NDC 42852-902-05 D-0999-2019
Class II · Moderate risk Terminated

MAGnesium 1gm sulfate

Reason Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Avella of Deer Valley, Inc. Store 38 NDC 42852-901-05 D-0998-2019
Class II · Moderate risk Terminated

Labetalol 20mg

Reason Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Avella of Deer Valley, Inc. Store 38 NDC 42852-822-71 D-0997-2019
Class II · Moderate risk Terminated

Express Gel Hand Sanitizer

Reason Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of malodor.

Ecolab Inc NDC 47593-502-49 D-1064-2019
Class II · Moderate risk Terminated

Quick-Care Foam Hand Sanitizer

Reason Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of malodor.

Ecolab Inc NDC 47593-491-85 D-1063-2019
Class II · Moderate risk Terminated

Moisturizing Gel Hand Sanitizer

Reason Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of malodor.

Ecolab Inc NDC 47593-489-33 D-1062-2019
Class II · Moderate risk Terminated

Advanced Gel Hand Sanitizer

Reason Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of malodor.

Ecolab Inc NDC 47593-488-49 D-1061-2019
Class II · Moderate risk Terminated

Gel Hand Sanitizer

Reason Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of malodor.

Ecolab Inc NDC 47593-487-49 D-1060-2019
Class II · Moderate risk Terminated

Moisturizing Lubricant Eye Drops

Reason Failed Stability Specification: out of specification results for Sodium Perborate

Akorn Inc NDC 00363-9651-01 D-0511-2019
Class II · Moderate risk Terminated

Dymista

Reason Defective Container: Potential for broken glass in the neck area of the glass bottles.

Mylan Pharmaceuticals Inc. NDC 0037-0245-23 D-0424-2019
Class II · Moderate risk Terminated

Divalproex Sodium Extended-release Tablets

Reason Failed Dissolution Specifications: Out of specification results observed for high dissolution.

Dr. Reddy's Laboratories, Inc. NDC 55111-533-01 D-0507-2019
Class II · Moderate risk Terminated

Ephedrine Sulfate

Reason Lack of assurance of sterility.

US Compounding Inc D-0508-2019
Class II · Moderate risk Terminated

LET Gel 4%

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

US Compounding Inc D-0482-2019
Class II · Moderate risk Terminated

BromSite

Reason Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.

Sun Pharmaceutical Industries, Inc. NDC 49708-754-41 D-0422-2019
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason Failed Impurities/Degradation Specifications: Elevated levels of a known impurity detected during 6-month RT stability interval.

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) D-1013-2019
Class II · Moderate risk Terminated

Fexofenadine HCl Tablets

Reason Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.

Mylan Pharmaceuticals Inc. NDC 0378-0782-93 D-0428-2019
Class II · Moderate risk Completed

Irbesartan and Hydrochlorothiazide Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Prinston Pharmaceutical Inc NDC 43547-330-03 D-0413-2019
Class II · Moderate risk Completed

Irbesartan and Hydrochlorothiazide Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Prinston Pharmaceutical Inc NDC 43547-331-09 D-0412-2019
Class II · Moderate risk Completed

Irbesartan and Hydrochlorothiazide Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Prinston Pharmaceutical Inc NDC 43547-331-03 D-0411-2019
Class II · Moderate risk Completed

Irbesartan and HydrochlorothiazideTablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Prinston Pharmaceutical Inc NDC 43547-330-09 D-0410-2019